Differential expression of epidermal growth factor receptor in melanocytic tumours demonstrated by immunohistochemistry and mRNA in situ hybridization

Australasian Journal of Dermatology

Volumn 40, Issue 1, 1999, Pages 19-24

  Sparrow, Louise E ^a   Heenan, Peter J ^b  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b Cutaneous Pathology   (Australia)

Author keywords

Dysplastic naevi; Melanocytic naevi; Melanoma; Spitz naevi

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; CONTROLLED STUDY; DYSPLASTIC NEVUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALIGNANT TRANSFORMATION; MELANOCYTIC NEVUS; MELANOMA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RNA ANALYSIS; SKIN CANCER; TISSUE SECTION;

CELL LINE; CHI-SQUARE DISTRIBUTION; DYSPLASTIC NEVUS SYNDROME; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MELANOMA; NEVUS, PIGMENTED; RECEPTOR, EPIDERMAL GROWTH FACTOR; REFERENCE VALUES; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SKIN; SKIN NEOPLASMS;

EID: 0032986967     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-0960.1999.00310.x     Document Type: Article

References (31)

1. Das M. Miyakavva T, Fox CF, Pruss RM, Aharonov A, Herschman HR. Specific radiolabeling of a cell surface receptor for epidermal growth factor. Proc. Natl Acad. Sei. USA 1977; 74: 2470-9.
2. Wong AJ, Bigner SH, Bigner D, Kinzler KVV, Hamilton SR, Vogelstein B. The TGF-a precursor expressed on the cell surface binds to the EGF-receptor on adjacent cells, leading to signal transduction. Cell 1989; 56: 495-506.
3. Di Fiore PP, Pierce JH, Fleming TP. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 1987; 51: 1063-70.
4. Gospodarowicz D. Epidermal and nerve growth factors in mammalian development. Ann. Rev. Pfiysiol. 1981; 43: 251-63.
5. Fukuyama R, Shimizu N. Expression of epidermal growth factor (EGF) and the EGF receptor in human tissues. J. Exp. Zool 1991; 258: 336-43.
6. Sainsbury JRC, Needham GK, Farndon FR, Malcolm AJ, Harris AL. Epidermal-growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1987; ii: 1398-402.
7. Bennett CR, Paterson IM, Corbishley CM, Luqmani YA. Expression of growth factor and epidermal growth factor receptor-encoded transcripts in human gastric tissues. Cancer Res. 1989; 49: 2104-11.
8. Liberman TA, Razon N, Bartal AD, Yarden Y, Schlessinger J, Soreq H. Expression of epidermal growth factor receptors in human brain tumors. Cancer Res. 1984; 44: 753-60.
9. Gorgoulis V, Giatromanolak A, Karmeris A. Epidermal growth factor receptor expression in squamous cell lung carcinomas: Immunohistochemical and gene analysis in formalin-fixed, paraffin-embedded material. Virchows Arch. A Pathol. Anat. Histopathol. 1993; 423: 295-302.
10. Neal D, Bennett MK, Hall R. Epidermal-growth factor receptors in human bladder cancer: Comparison of invasive and superficial tumours. Lancet 1985; i: 366-8.
11. Liberman TA, Nusbaum HR, Razon N. Amplification, enhanced expression, and possible rearrangement of EGF receptor gene in primary brain tumours of glial origin. Nature 1985; 313: 144-7.
12. Yamamoto T, Damta N, Kawano H. High incidence of amplification of the epidermal growth factor gene in human squamous carcinoma cell lines. Cancer Res. 1986; 46: 414-16.
13. Ozawa S, Ueda M, Ando N, Shimizu N, Abe O. Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas. Cancer 1989; 63: 2169-73.
14. Elder D, Rodeck U, Thurin J. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. Cancer Res. 1989; 49: 5091-6.
15. Real FX, Rettig VVG, Garin Chesa P, Melamed MR, Old LJ, Mendelsohn J. Expression of epidermal growth factor receptor in human cultured cells and tissues: Relationships to cell lineage and stage of differentiation. Cancer Res. 1986; 46: 4726-31.
16. de Wit PEJ, Moretti S, Koenders PG. Increasing epidermal growth factor receptor expression in human melanocytic tumor progression./ Invest. Dermatol. 1992; 99: 168-73.
17. Koprowski H, Herlyn M, Balaban G, Parmiter A, Ross A, Nowell P. Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanoma. Somat. Cell Mol Genet. 1985; 11: 297-302.
18. Maynard K, Parsons PG. Cross-sensitivity of methylating agents, hydroxyurea, and methotrexate in human tumor cells of the merphenotype. Cancer Res. 1986; 46: 5009-13.
19. Fabricant RN, DeLarco JE, Todaro J. Nerve growth factor receptor on human melanoma cells in culture. Proc. Natl Acad. Sei. USA 1976; 74: 565-9.
20. Sparrow LE, Soong R, Dawkins HJS, lacopetta BJ, Heenan PJ. p53 expression and mutation in naevi and melanomas. Melanoma Res. 1995; 5: 93-100.
21. Foss AJ, Alexander RA, Jefferies LW. Lightman S. Immunohistochemical techniques: The effect of melanin bleaching. Br. J. Biomed Sei. 1995; 52: 22-5.
22. Reed JA, McNutt NS, Albino AP. Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Aw. J. Pathol, 1994; 44: 329-36.
23. Mattel S, Colombo MP, Melani C, Silvani A, Parmiani G, Herlyn M. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int. J. Cancer 1994; 56:853-7.
24. Fleming MG, Swan LS, Heenan PJ. Seasonal variation in the proliferation fraction of Australian common nevi. Am. J. Dermatopathol. 1991; 13: 463-6.
25. Parmiter A, Nowell P. The cytogenetics of human malignant melanoma and premalignant lesions. Cancer Treatment Res. 1988; 43: 47-61.
26. Parmiter AH, Nowell PC. Cytogenetics of melanocytic tumors. J. Invest. Dermatol. 1993; 100 (Suppl. 3): S254-8.
27. Briand P, Vang Nielsen K, Madsen MW. Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal. Cancer Res. 1996; 56: 2039-44.
28. Collard JG, van de Poll M, Scheffer A. Location of genes involved in invasion and metastasis on human chromosome 7. Cancer Res. 1987; 47: 6666-70.
29. Nanney WB. Coffey RJ, Ellis DL. Expression and distribution of transforming growth factor-a within melanocytic lesions. J. Invest. Dermatol. 1994; 103: 707-14.
30. Ellis DL, King Jr LE, Nanney WB. Increased epidermal growth factor receptors in melanocytic lesions. J. Am. Acad. Dermatol. 1992; 27: 539-46.
31. Ellem KAO, Cullinan M, Baumann KC, Dunstan A. UVR induction of TGFa: A possible autocrine mechanism for the epidermal melanocytic response and for promotion of epidermal carcinogenesis. Carcinogenesis 1988; 9: 797-801.